Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001193125-25-297205

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 850,210 shares (grant or award)
  • CHIEF MEDICAL OFFICER returned 225,210 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Luptakova Katarina · CHIEF MEDICAL OFFICER

Table II: Derivative

11 lines
Date Transaction Shares Owned after D/I
2025-11-21 Grant or award : show line 1 in the form Stock Option (right to buy) +625,000 625,000 D
2025-11-21 Returned to the company : show line 2 in the form Stock Option (right to buy) −44,210 0 D
2025-11-21 Grant or award : show line 3 in the form Stock Option (right to buy) +44,210 44,210 D
2025-11-21 Returned to the company : show line 4 in the form Stock Option (right to buy) −15,000 0 D
2025-11-21 Grant or award : show line 5 in the form Stock Option (right to buy) +15,000 15,000 D
2025-11-21 Returned to the company : show line 6 in the form Stock Option (right to buy) −35,000 0 D
2025-11-21 Grant or award : show line 7 in the form Stock Option (right to buy) +35,000 35,000 D
2025-11-21 Returned to the company : show line 8 in the form Stock Option (right to buy) −25,000 0 D
Loading xslF345X05/ownership.xml…